Ambu AuraOnce Versus Ambu AuraGain LM in Children

Schulthess Klinik

Status: Unknown

Conditions: Airway Management

Treatments: Device: Ambu AuraOnce; Device: Ambu AuraGain

Study type: Interventional

Funder types: Other

Identifiers

NCT02811042

Schulthess_Anä_7

Details and patient eligibility

About

The investigators test the hypothesis that oropharyngeal leak pressure and fiberoptic position differ between the size 2 LM Ambu AuraOnce and the LM Ambu AuraGain in non-paralyzed anaesthetized pediatric patients.

Enrollment: 60 estimated patients

Sex: All

Ages: 1 to 16 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA I-II
• age 1 - 16 years
• minor surgery
• extraglottic airway device

Exclusion criteria

• age (<12 months, >16 years)
• weight (<12 kg, >50 kg)
• a known difficult airway
• risk of aspiration

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Oropharyngeal leak pressure

Active Comparator group

Description:

Ambu AuraOnce

Treatment:

Device: Ambu AuraOnce

Fiberoptic position

Experimental group

Description:

Ambu AuraGain

Treatment:

Device: Ambu AuraGain